Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study
以度伐利尤单抗为基础的一线化疗免疫疗法治疗晚期胆道癌：真实世界结果和预后因素——一项土耳其肿瘤协作组研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18010101
Efil, Safa Can; Kus, Fatih; Koylu, Bahadir; Durukan, Bekir Mert; Bayram, Selami; Guzel, Halil Goksel; Ozturk, Banu; Muglu, Harun; Bilici, Ahmet; Kose, Fatih; Alan, Ozkan; Karapelit Agitoglu, Eda; Guner, Gurkan; Besen, Ali Ayberk; Helvaci, Kaan; Araz, Murat; Kacan, Turgut; Arslan, Cagatay; Unal, Ahmet; Eniseler, Emine Bihter; Biter, Sedat; Ekinci, Ferhat; Aslan, Ferit; Unek, Ilkay Tugba; Tas, Semra; Acar, Omer; Ates, Ozturk; Sakalar, Teoman; Akbas, Sinem; Karakas, Hilal; Akinci, Muhammed Bulent; Yalcin, Bulent; Yalcin, Suayip; Sendur, Mehmet Ali Nahit
